CARDLYTICS INC
CDLXNASDAQTrading Snapshot
- Day Range
- $4.16 – $4.26
- 52-Week Range
- $3.49 – $32.80
- Volume
- $3.66B
- Avg Volume
- $2.66B
- Shares Outstanding
- 5.8M
- Next Earnings
- Oct 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $233M
- Last Q Revenue
- $37M
- P/E Ratio
- —
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-18.50
- Dividend Yield
- —
Why Investors Own CDLX
- ✓High-growth profile — revenue up -4.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 30% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CARDLYTICS INC
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call August 5, 2026 5:00 PM EDTCompany ParticipantsChris Cheng - Chief Legal OfficerAmit Gupta - CEO &...
Cardlytics Sees Q3 Sales $34.000M-$39.000M vs $38.594M Est
Cardlytics (NASDAQ:CDLX) sees Q3 sales of $34.000 million-$39.000 million vs $38.594 million analyst estimate.